90. Retinitis pigmentosa
103 clinical trials,   158 drugs   (DrugBank: 42 drugs),   52 drug target genes,   107 drug target pathways

Searched query = "Retinitis pigmentosa", "Rod dystrophy", "Rod-Cone Dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04636853
(ClinicalTrials.gov)
December 1, 202014/11/2020CB-PRP in Retinitis PigmentosaCord Blood Platelet-rich Plasma (CB-PRP) in Retinitis PigmentosaRetinitis PigmentosaBiological: Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP)Fondazione Policlinico Universitario Agostino Gemelli IRCCSNULLRecruiting18 Years70 YearsAll20Phase 3Italy
2NCT04252534
(ClinicalTrials.gov)
January 1, 201731/1/2020Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich PlasmaManagement of Retinitis Pigmentosa Via Repetitive Electromagnetic Stimulation and Autologous Platelet Rich PlasmaRetinitis PigmentosaCombination Product: PRP combined Magnovision;Biological: PRPAnkara Universitesi TeknokentNULLCompleted18 Years60 YearsAll60N/ANULL